STOCK TITAN
  1. Home
  2. RNAM

Avidity Biosciences (RNAM) Stock Price, News & Analysis

RNAM

Company Description

Avidity Biosciences (RNAM) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $11.2B.

For FY2025, Avidity Biosciences reported revenue of $18.8M with net income of -$684.6M and diluted earnings per share of $-4.97. The company operates at a net profit margin of -3650.4%.

This page collects what Stock Titan holds for RNAM, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$11.2B
Market Cap
154.7M
Shares outstanding

RNAM Rankings

Revenue
$18.8M
#2,905
Piotroski F-Score
2/9
#6,096

Latest News

View All

No recent news available for RNAM.

SEC Filings

View All

[SCHEDULE 13G/A] Avidity Biosciences (RNAM) Schedule 13G/A: RA Capital, Kolchinsky, Shah update ownership

[15-12G] Avidity Biosciences, Inc. SEC Filing

Avidity Biosciences has filed 2 recent SEC filings, including 1 Form SCHEDULE 13G/A, 1 Form 15-12G. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RNAM SEC filings →

Financial Highlights

View Full Financials

Avidity Biosciences generated $18.8M in revenue in FY2025, operating income reached -$745.9M (-3977.3% operating margin), and net income was -$684.6M, reflecting a -3650.4% net profit margin. Diluted earnings per share stood at $-4.97. The company generated -$650.4M in operating cash flow. With a current ratio of 9.20, the balance sheet reflects a strong liquidity position.

$18.8M
Revenue (FY2025)
-$684.6M
Net Income (FY2025)
$-4.97
Diluted EPS (FY2025)
-$650.4M
Operating Cash Flow
-3650.4%
Net Profit Margin
-3977.3%
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

RNAM Company Profile & Sector Positioning

Avidity Biosciences (RNAM) operates in the Biotechnology industry within the broader Healthcare sector.

Frequently Asked Questions

What is the market cap of Avidity Biosciences (RNAM)?

The market cap of Avidity Biosciences (RNAM) is approximately 11.2B. Learn more about what market capitalization means .

What is the revenue of Avidity Biosciences (RNAM) stock?

The FY2025 revenue of Avidity Biosciences (RNAM) is $18.8M, from its most recent completed fiscal year.

What is the net income of Avidity Biosciences (RNAM)?

The FY2025 net income of Avidity Biosciences (RNAM) is -$684.6M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Avidity Biosciences (RNAM)?

The diluted earnings per share (EPS) of Avidity Biosciences (RNAM) is $-4.97 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Avidity Biosciences (RNAM)?

The operating cash flow of Avidity Biosciences (RNAM) is -$650.4M. Learn about cash flow.

What is the profit margin of Avidity Biosciences (RNAM)?

The net profit margin of Avidity Biosciences (RNAM) is -3650.4%. Learn about profit margins.

What is the operating margin of Avidity Biosciences (RNAM)?

The operating profit margin of Avidity Biosciences (RNAM) is -3977.3%. Learn about operating margins.

What is the current ratio of Avidity Biosciences (RNAM)?

The current ratio of Avidity Biosciences (RNAM) is 9.20, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Avidity Biosciences (RNAM)?

The operating income of Avidity Biosciences (RNAM) is -$745.9M. Learn about operating income.